The Tissue Repair Evidence Summit (TRES) is a private, invitation-only meeting dedicated to advancing the clinical evidence base for cellular, acellular, and matrix-like products (CAMPS). Hosted in October 2025, TRES offers a focused platform for companies and investigators to present, publish, and validate their data in alignment with CMS and MAC expectations.

This is not a traditional conference. There are no general attendees or exhibition halls. Instead, TRES brings together a curated group of clinicians, researchers, and regulatory experts to assess and support the quality of submitted data ahead of policy-shaping deadlines.

TRES is delivered in partnership with the Serena Group and in association with the American Professional Wound Care Association (APWCA). The summit offers a full academic structure including abstract review, poster and podium presentation, and peer-reviewed publication via the International Journal of Tissue Repair (IJTR).

With up to 50 presentations expected from leading innovators in the space, TRES is designed to raise the bar on real-world clinical data and support the evidence needs of modern wound care.